Brind.

Regeneron Pharmaceuticals has committed to adopting Veeva Vault CRM globally for its commercial teams, utilizing Veeva's specialized platform services.

1 report, 1 independent Updated Aug 25

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Veeva Systems Regeneron Pharmaceuticals

Keep exploring

The entities involved

Veeva Systems
cloud computing company
- Veea Inc. is listed on the Nasdaq stock exchange, and Geode Capital Management LLC raised its stake in the company, filing with the SEC.Mon 00:19
- Aclarion and Veeva Systems are being monitored for share price volatility compared to the S&P 500 market index.Sun 14:42
Regeneron Pharmaceuticals
American pharmaceutical company
- Regeneron Pharmaceuticals and Wave Life Sciences are being compared as healthcare companies.Sun 14:10

Related events

Veeva Systems is strategically pivoting its operations, targeting the life sciences CRM market while transitioning from Salesforce's cloud infrastructure to its proprietary Vault platform.Jun 8
Veeva Systems reported successful Q2 earnings while securing new CRM adoption deals with Eli Lilly and Biogen.Aug 28

Coverage

Newest first; wire copies grouped

Aug 25prnewswire.com